There is an opportunity for biotech-style rewards hiding in an unexpected place: big pharma. Bristol-Myers Squibb and Celgene are set to close their $74 billion ...
Updated: 09/24/2019 04:23P
Where a defendant in a second-degree murder case challenged his sentence, arguing that the district court committed procedural and substantive error in its ...
Updated: 03/04/2019 04:33P